Friday, October 19, 2018

Agenda

Tuesday, April 17, 2018

08:45 - 09:15

Registration & Coffee

09:15 - 09:30

Welcome and Opening Remarks

    George Giannopoulos, Secretary General, Ministry of Health
09:30 - 11:30 SESSION 1 | EMBRACING A VALUE-BASED PARADIGM IN HEALTHCARE SYSTEMS

Chair:

    Vladimir Zah, Visiting Professor, Kozminski University, CEO at ZRx Outcomes Research Inc
VIDEO

"The Evolving Approach to Medicines Value Assessment in European Markets"

    Panos Kanavos, PhD, Associate Professor, Deputy Director, LSE Health, Department of Social Policy, London School of Economics

"Transferability and Relevance of Cost-Effectiveness Data between Countries"

    Michael Drummond, MCom, DPhil, Professor of Health Economics, Centre for Health Economics, University of York, Heslington, York, UK

"Do's and Don'ts in Managed Entry Agreements and negotiations"

    Katarzyna Kolasa, PhD, Professor of Health Economics Kozminski University, Head of Health Economics and Healthcare Management Department, Principal Senior Consultant, Market Access HEOR Straub Medical, Wangs Switzerland
    Dimitrios Kouvelas, Professor and Head of the Dept. of Clinical Pharmacology School of Medicine, Aristotle University of Thessaloniki

"Value-Based Healthcare in the UK"

    Eugena Stamuli, Visiting Research Fellow, University of York, Founder, PharmaEcons UK

Q&A

11:30 - 12:00

Coffee Break

12:00 - 12:15
Keynote Speech
    Makis Papataxiarchis, President PhRMA Innovation Forum (PIF), Chairman, AMCHAM Pharma Committee
12:15 - 14:00 SESSION 2 | KEY ISSUES IN THE IMPLEMENTATION OF HTA & THE NEW PHARMACEUTICAL POLICY

Chair:

    Magda Chatzikou, PhD, Managing Partner, PharmEcons Easy Access Ltd
    Ilias Giannoglou, Vice President, National Organization for Medicines (EOF)

"Environment and Prerequisites for the Application of HTA"

    Dimitris Pantazis, CEO, Institute of Pharmaceutical Research & Technology (IFET)

"HTA: A Value Based Framework to Assess Innovation"

    Yiannis Vlontzos, Vice - President, Responsible for HTA and Negotiation, Hellenic Association of Pharmaceutical Companies (SFEE), President and Managing Director of Merck

"HTA & Greek Pharmaceutical Industry"

    Markos Ollandezos, Scientific Director, Panhellenic Union of Pharmaceutical Companies (PEF)

"Patient Powered Registries: Useful for Health Technology Assessment or not?"

    Giorgos Kalamitsis, President of the Hellenic Liver Patient Association "Prometheus», President of the Patient Rights Control Committee

"Cyprus Experience: Progress on Implementing HTA"

    Antonis Kontemeniotis, MSc, Purchasing and Supply Directorate, Ministry of Health, Cyprus

Q&A

14:00 - 15:00

Lunch Break

15:00 - 16:30 PANEL DISCUSSION

THE NEW HTA BODY & NEGOTIATION COMMITTEE IN GREECE: PRINCIPLES AND THE WAY FORWARD

Chair:
Dimitris Pantazis, CEO, Institute of Pharmaceutical Research & Technology (IFET)

  • Panagiotis Georgakopoulos, Vice President, National Organization for the Provision of Healthcare Services (EOPYY)
  • Filippos Tarantilis, Deputy CEO, Laiko General Hospital of Athens, Member of the Working Committee for the Establishment of an HTA Body in Greece
  • Despoina Makridaki, President, Pan-Hellenic Association of Hospital Pharmacists (P.E.F.N.I.), Vice President, National Organization for Medicines (EOF)
  • Ioannis Podimatas, Special Advisor to the Secretary General, Ministry of Health
  • Vasileios Pentafragas, Executive Director, Panhellenic Union of Pharmaceutical Industry (PEF)

Q&A

16:30

Conclusions

The agenda is preliminary.

  • ORGANIZED BY
  • IN COOPERATION WITH
  • SPONSOR
  • SUPPORTERS
  • MEDIA PARTNER
  • MEDIA SPONSORS
  • CONFERENCE EXPERIENCE SPONSOR

© 2018 Boussias Communications, all rights reserved. info@boussias.com, T:210 6617777, F:210 6617778

Designed by Boussias
New Media Team